Abbott Laboratories : ABT

All Abbott Laboratories Articles

311 Articles

Jon C. Ogg | Jun 21, 2017 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Abbott Labs, AMD, Chesapeake, Intel, PayPal, Target, Weatherford, Whiting Petroleum and Many More

The top analyst upgrades, downgrades and other research calls from Wednesday include Abbott Laboratories, Advanced Micro Devices, Chesapeake Energy, Intel,…

Lee Jackson | Apr 17, 2017 at 10:00 AM EDT

Top Dividend Pharmaceutical Stocks Safe Bet for Rest of 2017

With interest rates once again dropping as the geopolitical worries ratchet up, investors are concerned about owning good stocks and…

Lee Jackson | Mar 17, 2017 at 10:10 AM EDT

Merrill Lynch Says Time to Buy These 5 Top Dividend Aristocrat Stocks

These five Dividend Aristocrats, if purchased soon, should reward investors with a payout early next quarter.

Jon C. Ogg | Mar 14, 2017 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Mobileye, Occidental, Oracle, Disney, Wal-Mart and Many More

The top analyst upgrades, downgrades and initiations seen on Tuesday include Mobileye, Occidental Petroleum, Oracle, Walt Disney, Wal-Mart.

Lee Jackson | Mar 1, 2017 at 9:15 AM EST

Top Analysts Upgrades and Downgrades: Abbott Labs, General Dynamics, Nexstar Media, Owens Corning, Palo Alto Networks, Salesforce and More

Wednesday’s top analyst upgrades, downgrades and initiations include Abbott Labs, General Dynamics, Nexstar Media, Owens Corning, Palo Alto Networks and…

Lee Jackson | Feb 16, 2017 at 10:05 AM EST

5 High-Dividend Growth Stocks to Buy for the Coming Volatility

With inflation, higher interest rates and a host of potential volatility events around the corner, it makes sense now to…

Lee Jackson | Feb 9, 2017 at 8:35 AM EST

5 Safe Dividend Stocks to Own If the Big Market Correction Comes

These five stocks pay solid distributions, are not trading at all-time highs and are rated Buy at Merrill Lynch. They…

Lee Jackson | Jan 23, 2017 at 8:25 AM EST

Top Analysts Love These 5 Buy-Rated Dividend Aristocrats for 2017

The pricier the market gets, the more it makes sense to stay with industry leaders, especially those that have paid…

Trey Thoelcke | Jan 12, 2017 at 6:25 AM EST

The 6 Most Shorted NYSE Stocks

Bank of America, Chesapeake Energy and General Electric all saw double-digit percentage drops in their short interest in the waning…

Lee Jackson | Jan 3, 2017 at 8:25 AM EST

5 Merrill Lynch Stocks to Buy That Are 2017 Dividend Aristocrats

For more conservative investors looking for growth and income, these stocks make good sense for 2017 and beyond.

Lee Jackson | Dec 24, 2016 at 10:10 AM EST

Massive Media and Retail Buys Highlight Insider Buying as Trump Rally Slows: Fred’s, 21st Century Fox, Newcastle Investment, Wynn Resorts, Inovalon and More

The pending holiday didn’t slow insiders from buying shares, and we continued to see some strong trading during the week.

Trey Thoelcke | Dec 12, 2016 at 6:40 AM EST

The 6 Most Shorted NYSE Stocks

Judging by moves among the most shorted stocks traded on the New York Stock Exchange, short sellers took a cautious…

Lee Jackson | Dec 5, 2016 at 8:20 AM EST

4 Merrill Lynch Med Tech and Drug Dividend Stocks to Buy With Huge 2017 Potential

These are stocks that make good sense for investors looking to add to their overall equity holdings. They are all…

Lee Jackson | Dec 1, 2016 at 8:10 AM EST

Analyst’s Top Pharmaceutical Buys Offer Big Dividends and Growth Potential

With the top pharmaceutical stocks trailing the market by a large margin, they are starting to look very attractive for…

Lee Jackson | Nov 20, 2016 at 10:20 AM EST

Massive Energy and Health Care Trades Highlight Insider Buying: Abbott Labs, Baker Hughes, Datawatch, Impac Mortgage and More

Last week, following the election, the insiders were back with a vengeance, and the buyers were out in full force.

1 … 6 7 8 9 10 … 21

Abbott Laboratories : ABT

All Abbott Laboratories Articles

Top Analyst Upgrades and Downgrades: Abbott Labs, AMD, Chesapeake, Intel, PayPal, Target, Weatherford, Whiting Petroleum and Many More

Top Dividend Pharmaceutical Stocks Safe Bet for Rest of 2017

Merrill Lynch Says Time to Buy These 5 Top Dividend Aristocrat Stocks

Top Analyst Upgrades and Downgrades: Mobileye, Occidental, Oracle, Disney, Wal-Mart and Many More

Top Analysts Upgrades and Downgrades: Abbott Labs, General Dynamics, Nexstar Media, Owens Corning, Palo Alto Networks, Salesforce and More

5 High-Dividend Growth Stocks to Buy for the Coming Volatility

5 Safe Dividend Stocks to Own If the Big Market Correction Comes

Top Analysts Love These 5 Buy-Rated Dividend Aristocrats for 2017

The 6 Most Shorted NYSE Stocks

5 Merrill Lynch Stocks to Buy That Are 2017 Dividend Aristocrats

Massive Media and Retail Buys Highlight Insider Buying as Trump Rally Slows: Fred’s, 21st Century Fox, Newcastle Investment, Wynn Resorts, Inovalon and More

The 6 Most Shorted NYSE Stocks

4 Merrill Lynch Med Tech and Drug Dividend Stocks to Buy With Huge 2017 Potential

Analyst’s Top Pharmaceutical Buys Offer Big Dividends and Growth Potential

Massive Energy and Health Care Trades Highlight Insider Buying: Abbott Labs, Baker Hughes, Datawatch, Impac Mortgage and More

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Abbott Laboratories : ABT

All Abbott Laboratories Articles

Top Analyst Upgrades and Downgrades: Abbott Labs, AMD, Chesapeake, Intel, PayPal, Target, Weatherford, Whiting Petroleum and Many More

Top Dividend Pharmaceutical Stocks Safe Bet for Rest of 2017

Merrill Lynch Says Time to Buy These 5 Top Dividend Aristocrat Stocks

Top Analyst Upgrades and Downgrades: Mobileye, Occidental, Oracle, Disney, Wal-Mart and Many More

Top Analysts Upgrades and Downgrades: Abbott Labs, General Dynamics, Nexstar Media, Owens Corning, Palo Alto Networks, Salesforce and More

5 High-Dividend Growth Stocks to Buy for the Coming Volatility

5 Safe Dividend Stocks to Own If the Big Market Correction Comes

Top Analysts Love These 5 Buy-Rated Dividend Aristocrats for 2017

The 6 Most Shorted NYSE Stocks

5 Merrill Lynch Stocks to Buy That Are 2017 Dividend Aristocrats

Massive Media and Retail Buys Highlight Insider Buying as Trump Rally Slows: Fred’s, 21st Century Fox, Newcastle Investment, Wynn Resorts, Inovalon and More

The 6 Most Shorted NYSE Stocks

4 Merrill Lynch Med Tech and Drug Dividend Stocks to Buy With Huge 2017 Potential

Analyst’s Top Pharmaceutical Buys Offer Big Dividends and Growth Potential

Massive Energy and Health Care Trades Highlight Insider Buying: Abbott Labs, Baker Hughes, Datawatch, Impac Mortgage and More

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do